O'Donnell Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,412
Closed -$208K 77
2026
Q1
$208K Buy
+7,412
New +$197K 0.07% 59
2023
Q4
Sell
-6,053
Closed -$201K 38
2023
Q3
$201K Hold
6,053
0.11% 29
2023
Q2
$222K Sell
6,053
-58
-0.9% -$2.26K 0.13% 23
2023
Q1
$249K Buy
6,111
+44
+0.7% +$1.9K 0.44% 13
2022
Q4
$311K Sell
6,067
-168
-3% -$8.05K 2.85% 11
2022
Q3
$273K Sell
6,235
-66
-1% -$3.21K 0.95% 18
2022
Q2
$331K Sell
6,301
-15
-0.2% -$764 0.27% 23
2022
Q1
$327K Buy
6,316
+37
+0.6% +$1.92K 0.15% 30
2021
Q4
$341K Buy
6,279
+1,201
+24% +$59.5K 0.16% 33
2021
Q3
$218K Buy
+5,078
New +$225K 0.1% 45

Other funds holding PFE

O'Donnell Financial Services's PFE Position: Q2 2026 in Review

O'Donnell Financial Services sold out of Pfizer (PFE) in Q2 2026, closing a stake of 7,412 shares — an estimated $208K sold.

O'Donnell Financial Services first reported a position in PFE in Q3 2021 and held it in 10 quarters. The position peaked at $341K in Q4 2021. 2,834 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • O'Donnell Financial Services reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • O'Donnell Financial Services sold 7,412 Pfizer shares in Q2 2026, an estimated $208K.
  • O'Donnell Financial Services first reported a position in Pfizer in Q3 2021 and held it in 10 quarters.
  • O'Donnell Financial Services's Pfizer position peaked at $341K in Q4 2021.
  • 2,834 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on O'Donnell Financial Services's 13F filing for Q2 2026, filed 12 Aug 2026.